Evercore ISI Sticks to Their Buy Rating for Teva Pharmaceutical (TEVA)
Evercore ISI analyst Umer Raffat maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report) on January 31. The company’s shares ...
Teva Pharmaceutical (TEVA) Gets a Buy from Argus Research
Argus Research analyst Jasper Hellweg maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report) yesterday. The company’s shares ...